Caffeic acid phenethyl ester protects the brain against hexavalent chromium toxicity by enhancing endogenous antioxidants and modulating the JAK/STAT signaling pathway - 08/06/17
, Sanaa M. Abd El-TwabBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 9 |
| Iconographies | 8 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | Hexavalent chromium activates JAK/STAT signaling pathway. |
• | Caffeic acid phenethyl ester exerts neuroprotective effect against chromium VI. |
• | Caffeic acid phenethyl ester modulates JAK/STAT signaling and attenuates oxidative stress and inflammation. |
Abstract |
Hexavalent chromium [Cr(VI)] is commonly used in industry, and is a proven toxin and carcinogen. However, the information regarding its neurotoxic mechanism is not completely understood. The present study was designed to scrutinize the possible protective effects of caffeic acid phenethyl ester (CAPE), a bioactive phenolic of propolis extract, on Cr(VI)-induced brain injury in rats, with an emphasis on the JAK/STAT signaling pathway. Rats received 2mg/kgK2CrO4 and concurrently treated with 20mg/kg CAPE for 30 days. Cr(VI)-induced rats showed a significant increase in cerebral lipid peroxidation, nitric oxide and pro-inflammatory cytokines, with concomitantly declined antioxidants and acetylcholinesterase. CAPE attenuated oxidative stress and inflammation and enhanced antioxidant defenses in the cerebrum of rats. Cr(VI) significantly up-regulated JAK2, STAT3 and SOCS3, an effect that was reversed by CAPE. In conclusion, CAPE protects the brain against Cr(VI) toxicity through abrogation of oxidative stress, inflammation and down-regulation of JAK2/STAT3 signaling in a SOCS3-independent mechanism.
Le texte complet de cet article est disponible en PDF.Keywords : Hexavalent chromium, Oxidative stress, Inflammation, JAK/STAT, SOCS3
Plan
Vol 91
P. 303-311 - juillet 2017 Retour au numéro
Article précédent
- Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy
- Baomin Zhu, Lianling Yu, QingCai Yue
- LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer
- Wei Zhang, Shenghong Shi, Jing Jiang, Xujun Li, Hongfeng Lu, Feng Ren
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?